A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Glioblastoma · Recurrent Glioblastoma · Brain Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Ugonma Chukwueke, MD) · Ugonma_Chukwueke@DFCI.HARVARD.EDU · 617-632-2166
Contact: Principal Investigator (Ugonma Chukwueke, MD)
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Ugonma Chukwueke, MD) · Ugonma_Chukwueke@DFCI.HARVARD.EDU · 617-632-2166
Contact: Principal Investigator (Ugonma Chukwueke, MD)
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Contact: Study coordinator (Isabel Arrillaga-Romany, MPH, PhD) · iarrillaga@mgh.harvard.edu
Contact: Principal Investigator (Isabel Arrillaga-Romany, MD, PhD)

Study leads

Ugonma Chukwueke, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov Contact study team (email)